Peter Damsbo
Chief Tech/Sci/R&D Officer at Coegin Pharma AS
Profile
Peter Damsbo is currently the Chief Medical Officer at Coegin Pharma.
AS since 2010 and a Partner at Ventac Partners GmbH since 2009.
He previously worked as the Medical Director-Diabetes at Novo Nordisk A from 2011 to 2012, and at Novo Nordisk, Inc. as a Medical Director-Diabetes.
He also served as the Chief Medical Officer at Zealand Pharma A and as a Research Fellow at Steno Diabetes Center A.
Dr. Damsbo holds a doctorate degree from the University of Copenhagen.
Peter Damsbo active positions
| Companies | Position | Start |
|---|---|---|
Coegin Pharma AS
 Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway. | Chief Tech/Sci/R&D Officer | 2010-04-05 |
Ventac Partners GmbH
 Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Corporate Officer/Principal | 2009-05-31 |
Former positions of Peter Damsbo
| Companies | Position | End |
|---|---|---|
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Corporate Officer/Principal | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
| Steno Diabetes Center A/S | Corporate Officer/Principal | - |
| ZEALAND PHARMA A/S | Chief Tech/Sci/R&D Officer | - |
Training of Peter Damsbo
| University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ZEALAND PHARMA A/S | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| Private companies | 4 |
|---|---|
Coegin Pharma AS
Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway. | Health Technology |
Ventac Partners GmbH
Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Commercial Services |
| Steno Diabetes Center A/S | |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
- Stock Market
- Insiders
- Peter Damsbo
